Keywords : In Vitro Diagnostic, in vitro diagnostics, in vitro, microbiology, Haematology, POC, point-of-care-testing, IVD test, IVD, Microbiology Test, POC testing
Report Details How will the in vitro diagnostics (IVD) market develop this decade? Our report shows you potential revenues to 2022, discussing opportunities and prospects. Through our research and analysis we aim to save you time and help in your decisions. Our new study shows you potential revenues to 2022 for in vitro diagnostics at total world, submarket and national levels. What technologies and applications will expa...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Report Details
How will the in vitro diagnostics (IVD) market develop this decade? Our report shows you potential revenues to 2022, discussing opportunities and prospects. Through our research and analysis we aim to save you time and help in your decisions.
Our new study shows you potential revenues to 2022 for in vitro diagnostics at total world, submarket and national levels. What technologies and applications will expand that market? What effects will changes have? You will find predictions and answers.
In our report you will find revenue predictions for clinical chemistry, immunochemistry, haematology, microbiology, genetic testing, and point of care testing (POCT).
You will find coverage of Roche, Siemens, Abbott Laboratories, Danaher and Becton Dickinson & Company.
We help you to assess the in vitro diagnostics industry and market's strengths, weaknesses, trends and potential revenues to 2022. You will see where those technologies are heading.
Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.
Original analysis with revenues, growth rates, market shares, opinion and discussions
You will find revenue forecasts, growth rates, market shares, a SWOT review, opinions from our survey and discussions of technologies and companies. We provide 68 tables and charts and two research interviews (shown in the accompanying lists).
Why you should buy In Vitro Diagnostics: World Market Outlook 2012-2022
In this report, you will receive the following benefits in particular:
• You will discover revenue forecasts to 2021 for the world in vitro diagnostics market and its main components, seeing where the highest revenue growth will occur
• You will find revenue forecasts to 2021 for IVD technologies, assessing their commercial potential and applications
• You will discover revenue forecasts to 2021 for leading national markets (US, Japan, Germany, France, Spain, UK, Italy, China and India), seeing growth trends
• You will assess leading companies in IVD, discovering their activities and outlooks
• You will investigate competition and opportunities influencing the IVD industry and market from 2011 onwards
• You will see what will stimulate and restrain the IVD industry and market from 2011
• You will identify diagnostic needs and commercial opportunities, including those for personalised medicine
• You will analyse opportunities and challenges for established companies and those seeking to enter the IVD market
• You will view opinions from our industry survey, receiving full interview transcripts.
In Vitro Diagnostics: World Market Outlook 2012-2022 shows you opportunities, challenges and revenue forecasts. That mix of quantitative and qualitative analysis sets our report apart. We tackle crucial questions in the in vitro diagnostics industry and market, aiming to save you time and effort.
You can order this report today
Order our report now to gain industry and market analysis for medical diagnostic tests. Our report is for everybody interested in market analysis, product development, sales and marketing for diagnostic tests and devices. You will find predictions and answers. Don't miss out - please order our report now.
Global In Vitro Diagnostic Industry
Table of Contents
1. Executive Summary
1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to the Report
2. Introduction to In Vitro Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 The US Classification
2.2.2 The EC (European Commission) Classification
2.2.3 Regulatory Issues in the IVD Market
2.2.3.1 Regulation of IVD Tests
2.2.3.2 Lack Of Clarity Can Be Costly
2.3 Types of IVD Tests
2.3.1 Point Of Care Diagnostics
2.3.2 Clinical Chemistry
2.3.3 Microbiology
2.3.3.1 Regulatory Differences With IVD Microbiology Tests
2.3.4 Haematology
2.3.5 Immunochemistry
2.3.6 Genetic testing
3. The Global In Vitro Diagnostics Market, 2011-2022
3.1 The Global Medical Devices Market, 2011
3.2 In Vitro Diagnostics Market, 2011
3.3 Global IVD Market Forecast, 2012-2022
3.3.1 IVD Market: Industry Trends, 2012-2022
3.3.1.1 Advances In Technology Driving The IVD Market
3.3.1.2 Decentralisation
3.3.1.3 Increased Awareness Through Globalisation
4. In Vitro Diagnostics Market Sectors, 2011-2022
4.1 Point-Of-Care Diagnostics
4.1.1 POC Diagnostics Market, 2011
4.1.2 POC Diagnostics: Market Forecast, 2012-2022
4.1.3 POC Diagnostics: Market Trends, 2012-2022
4.1.3.1 New Tests Targeting Biomarkers
4.1.3.2 Company Competition Driving Product Innovation
4.1.3.3 Infectious Diseases Prompting Growth of POC
4.2 Clinical Chemistry
4.2.1 Clinical Chemistry: Market Forecast, 2012-2022
4.2.2 Clinical Chemistry: Market Trends, 2012-2022
4.3 Immunochemistry
4.3.1 Immunochemistry: Market Forecast, 2012-2022
4.3.2 Immunochemistry: Market Trends, 2012-2022
4.3.2.1 Immunoassays And Automated Systems Prompting Market Growth
4.3.2.2 Strong Growth in China and India
4.4 Haematology
4.4.1 Haematology: Market Forecast, 2012-2022
4.4.2 Haematology: Market Trends, 2012-2022
4.5 Microbiology
4.5.1 Microbiology: Market Forecast, 2012-2022
4.5.2 Microbiology: Market Trends, 2012-2022
4.6 Genetic Testing
4.6.1 Genetic Testing: Market Forecast, 2012-2022
4.6.2 Genetic Testing: Market Trends, 2012-2022
4.6.2.1 Cytogenetic Tests to Drive Market Growth
4.6.2.2 Direct-To-Consumer (DTC) Genetic Screening
4.6.2.3 Theranostics: Targeting Unmet Needs Through DNA Tests
5. Leading Companies in the IVD Market
5.1 Fragmented Market
5.2 IVD Market: Breakdown By Company, 2011
5.3 Roche
5.3.1 Sales and Recent Performance Analysis
5.3.1.1.Roche Diagnostics
5.4 Siemens
5.4.1 Sales And Recent Performance Analysis
5.4.1.1 Healthcare Sector
5.5 Danaher
5.5.1 Sales and Recent Performance Analysis
5.5.1.1 Life Sciences & Diagnostics
5.6 Abbott Laboratories
5.6.1 Sales and Recent Performance Analysis
5.7 Becton Dickinson
5.7.1 Sales and Recent Performance Analysis
5.7.1.1 BD Diagnostics
5.8 Other Companies
6. Leading National IVD Markets, 2011-2022
6.1 Regional Breakdown of The Global IVD Market, 2011
6.2 The Global IVD Market: Regional Forecast, 2012-2022
6.3 The US Market
6.3.1 Increased Levels of Molecular Testing in The US
6.3.2 Increased Use of Mobile Applications
6.4 The European Market
6.4.1 Germany And France
6.4.2 Italy
6.4.3 Spain
6.4.4 UK
6.5 The Japanese Market
6.6 The Chinese Market
6.7 The Indian Market
7. SWOT Analysis of the IVD Market, 2012
7.1 In Vitro Diagnostics: Industry Trends
7.2 Strengths
7.2.1 Patient Demographics
7.2.2 Technological Advancements
7.3 Weaknesses
7.3.1 Regulatory Board Approvals
7.3.2 Reimbursement Issues
7.4 Opportunities
7.4.1 Globalisation
7.4.2 Molecular Diagnostics
7.5 Threats
7.5.1 Medical Device Excise Tax
7.5.2 Convergence
8. Opinions from Our Industry Survey
8.1 Godwin Liu, Marketing Manager, Shenzhen Mindray Bio-Medical Electronics Co.
8.1.1 Unmet Needs in the IVD Market
8.1.2 Growth in the IVD Sector
8.1.3 Challenges Faced by the IVD Market
8.1.4 Market Expansion for IVD Products
8.2 Interview 2: Director of a Diagnostics Company
8.2.1 Most-Promising Therapeutic Areas for IVD
8.2.2 Unmet Medical Needs in IVD
8.2.3 Greatest Obstacles to Market Growth
8.2.4 Prospects for IVD Market Growth in Developing Countries
8.2.5 Prospects for Theranostics
9. Conclusions
9.1 Overview
9.2 Point-Of-Care (POC) Testing Will Remain the Largest Segment
9.3 Prominent Companies in the Market
9.4 World Market Forecasts
9.5 Future Outlook and Concluding Remarks
Appendix A
Appendix B
Visiongain report evaluation form
List Of Tables
Table 2.1 Advantages and Disadvantages of POC Diagnostics
Table 2.2 Genetic In Vitro Diagnostic Tests Currently Available, 2011
Table 3.1 The Medical Device Market: 2011 Net Sales ($bn), By Sector
Table 3.2 Diagnostic Devices Market: 2011 Net Sales ($bn) and Market Shares (%), By Category
Table 3.3 The IVD Market: 2011 Net Sales ($bn) and Market Shares (%), By Sector
Table 3.4 Global IVD Market Forecast ($bn), By Sector, 2011-2022
Table 4.1 POC Diagnostics: 2011 Net Sales ($bn) & Market Shares (%), By Test
Table 4.2 Point-Of-Care (POC) Diagnostics: Market Forecast ($bn), 2011-2022
Table 4.3 Clinical Chemistry: Market Forecast ($bn), 2011-2022
Table 4.4 Immunochemistry: Market Forecast ($bn), 2011-2022
Table 4.5 Haematology: Market Forecast ($bn), 2011-2022
Table 4.6 Microbiology: Market Forecast ($bn), 2011-2022
Table 4.7 Genetic Testing: Market Forecast ($bn), 2011-2022
Table 5.1 Leading Companies in the IVD Market: 2011 Net Sales ($bn) and Market Shares (%)
Table 5.2 Roche: 2011 Net Sales ($bn) & Market Shares (%), By Sector
Table 5.3 Roche Diagnostics: 2011 Net Sales ($bn) & Market Shares (%), By Product Line
Table 5.4 Siemens: 2011 Net Sales ($bn) and Market Shares (%), By Sector
Table 5.5 Siemens Healthcare Sector: 2011 Net Sales & Percentage Share (%), By Product Group
Table 5.6 Danaher: 2011 Net Sales ($bn) and Market Shares (%), By Sector
Table 5.7 Abbott: 2011 Net Sales ($bn) & Market Shares (%), By Sector
Table 5.8 Becton Dickinson: 2011 Net Sales ($bn) & Market Shares (%), By Sector
Table 5.9 Other Companies Operating in the IVD Market, 2012
Table 6.1 IVD Market: 2011 Sales ($bn) and Market Shares (%), By Region
Table 6.2 IVD Market: Regional Market Forecast ($bn, AGR %, CAGR %), 2011-2022
Table 6.3 The Leading European IVD Market: 2011 Market Value ($bn), European Market Shares (%) and Global Market Shares (%), By Region
Table 6.4 The European IVD Market Forecast ($bn, AGR %, CAGR %) By Region, 2011-2022
Table 7.1 SWOT Analysis of the Global IVD Market, 2012-2022
Table 9.1 IVD Market Forecast ($bn), By Sector In 2011, 2016, 2018 and 2022
List Of Figures
Figure 3.1 The Medical Device Market: Global Market Shares (%) by Sector, 2011
Figure 3.2 Diagnostic Devices Market: 2011 Market Shares (%), By Category
Figure 3.3 IVD Market: 2011 Net Sales ($bn), By Sector
Figure 3.4 IVD Market: 2011 Market Shares (%), By Sector
Figure 3.5 Global IVD Market Forecast ($bn), 2011-2022
Figure 4.1 POC Diagnostics: 2011 Net Sales ($bn), By Test
Figure 4.2 POC Diagnostics: 2011 Market Shares (%), By Test
Figure 4.3 Point-Of-Care (POC) Diagnostics: Market Forecast ($bn), 2011-2022
Figure 4.4 Clinical Chemistry: Market Forecast ($bn), 2011-2022
Figure 4.5 Immunochemistry: Market Forecast ($bn), 2011-2022
Figure 4.6 Haematology: Market Forecast ($bn), 2011-2022
Figure 4.7 Microbiology: Market Forecast ($bn), 2011-2022
Figure 4.8 Genetic Testing: Market Forecast ($bn), 2011-2022
Figure 5.1 Leading Companies in the IVD Market: 2011 Net Sales ($bn)
Figure 5.2 Leading Companies in the IVD Market: 2011 Market Shares (%)
Figure 5.3 Roche: 2011 Market Shares (%), By Sector
Figure 5.4 Roche Diagnostics: 2011 Net Sales ($bn), By Product Line
Figure 5.5 Roche Diagnostics: 2011 Market Shares (%), By Product Line
Figure 5.6 Siemens: 2011 Market Shares (%), By Sector
Figure 5.7 Siemens Healthcare Sector: 2011 Market Shares (%), By Product Group
Figure 5.8 Danaher: 2011 Net Sales ($bn), By Sector
Figure 5.9 Danaher: 2011 Market Shares (%), By Sector
Figure 5.10 Abbott: 2011 Net Sales ($bn) By Sector
Figure 5.11 Abbott: 2011 Market Shares (%), By Sector
Figure 5.12 Becton Dickinson: 2011 Market Shares (%), By Sector
Figure 6.1 IVD Market: 2011 Sales ($bn), By Region
Figure 6.2 IVD Market: 2011 Market Shares (%), By Region
Figure 6.3 The US IVD Market Forecast ($bn), 2011-2022
Figure 6.4 The European IVD Market: 2011 Sales ($bn), By Region
Figure 6.5 The European IVD Market: 2011 Market Shares (%), By Region
Figure 6.6 The European IVD Market Forecast ($bn), 2011-2022
Figure 6.7 The German and French IVD Market Forecasts ($bn), 2011-2022
Figure 6.8 The Italian IVD Market Forecasts ($bn), 2011-2022
Figure 6.9 The Spanish IVD Market Forecasts ($bn), 2011-2022
Figure 6.10 The UK IVD Market Forecasts ($bn), 2011-2022
Figure 6.11 The Japanese IVD Market Forecasts ($bn), 2011-2022
Figure 6.12 The Chinese IVD Market Forecasts ($bn), 2011-2022
Figure 6.13 The Indian IVD Market Forecasts ($bn), 2011-2022
Figure 9.1 Projected IVD Market Growth for 2016, 2018 and 2022, By Sector
Figure 9.2 Projected Total IVD Market Size ($bn) In 2011, 2016, 2018 and 2022
Companies Listed
3M
Abbott Laboratories
Agilent
Alere
Arkray
Bayer
BD Diagnostics
Becton Dickinson
Biomerieux
BioRad
Cardiogenics
Claros Diagnostics
Danaher
Fujirebio
GenProbe
Hologic
Instrumentation Labs
Ipsogen
Johnson & Johnson
Luminex
Mindray
Miraca Life Sciences
Myriad Genetics
Novartis
Polymedco Inc.
Qiagen
Quest Diagnostics
Response Biomedical Corp.
Roche
Saladax
SDIX
Siemens
Sysmex
Transasia Bio Medicals Ltd.
Vermillion
